4^th World Congress On Protein and Bio-Medical Engineering

March 15-16, 2018

Protein and Bio-Medical Engineering - A Roadmap for Advanced Research Initiatives

Submit Abstract Register Now Sessions & Tracks Program Schedule Reader Base Awards Nomination

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Zhiwei Song

Principal Scientist
Bioprocessing Technology Institute (BTI) of A*STAR
Singapore

Biography

Dr. Zhiwei Song obtained his Ph.D. degree in Biochemistry from the University of Michigan where he studied plant lectins and protein glycosylation in cancer cells. His post-doc work was completed in the Biology Department at MIT where he studied genetic control of apoptosis. In 2002, Dr. Song moved to Singapore. Now he is a Principal Scientist at the Bioprocessing Technology Institute (BTI) of A*STAR. His research has been focused on protein glycosylation, glycoengineering of CHO cells, production of recombinant antibodies using CHO cells and apoptotic cell death in cultured mammalian cells.

Research Interest

His research has been focused on protein glycosylation, glycoengineering of CHO cells, production of recombinant antibodies using CHO cells and apoptotic cell death in cultured mammalian cells.